165 related articles for article (PubMed ID: 33845591)
1. Recent progress in small-molecule inhibitors for critical therapeutic targets of necroptosis.
Fang Z; Wei H; Gou W; Chen L; Bi C; Hou W; Li Y
Future Med Chem; 2021 May; 13(9):817-837. PubMed ID: 33845591
[TBL] [Abstract][Full Text] [Related]
2. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis.
Fauster A; Rebsamen M; Huber KV; Bigenzahn JW; Stukalov A; Lardeau CH; Scorzoni S; Bruckner M; Gridling M; Parapatics K; Colinge J; Bennett KL; Kubicek S; Krautwald S; Linkermann A; Superti-Furga G
Cell Death Dis; 2015 May; 6(5):e1767. PubMed ID: 25996294
[TBL] [Abstract][Full Text] [Related]
3. Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives.
Zhuang C; Chen F
J Med Chem; 2020 Feb; 63(4):1490-1510. PubMed ID: 31622096
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation.
Duan X; Liu X; Liu N; Huang Y; Jin Z; Zhang S; Ming Z; Chen H
Cell Death Dis; 2020 Feb; 11(2):134. PubMed ID: 32075957
[TBL] [Abstract][Full Text] [Related]
5. Identification and Characterization of NTB451 as a Potential Inhibitor of Necroptosis.
In EJ; Lee Y; Koppula S; Kim TY; Han JH; Lee KH; Kang TB
Molecules; 2018 Nov; 23(11):. PubMed ID: 30400632
[TBL] [Abstract][Full Text] [Related]
6. Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis.
Hou J; Ju J; Zhang Z; Zhao C; Li Z; Zheng J; Sheng T; Zhang H; Hu L; Yu X; Zhang W; Li Y; Wu M; Ma H; Zhang X; He S
Cell Death Dis; 2019 Jun; 10(7):493. PubMed ID: 31235688
[TBL] [Abstract][Full Text] [Related]
7. Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3.
Chen X; Zhuang C; Ren Y; Zhang H; Qin X; Hu L; Fu J; Miao Z; Chai Y; Liu ZG; Zhang H; Cai Z; Wang HY
Br J Pharmacol; 2019 Jun; 176(12):2095-2108. PubMed ID: 30825190
[TBL] [Abstract][Full Text] [Related]
8. Protein-Bound Polysaccharides from
Pawlikowska M; Jędrzejewski T; Brożyna AA; Wrotek S
Cell Physiol Biochem; 2020 Jun; 54(4):591-604. PubMed ID: 32531147
[TBL] [Abstract][Full Text] [Related]
9. High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway.
Xu Y; Gao H; Hu Y; Fang Y; Qi C; Huang J; Cai X; Wu H; Ding X; Zhang Z
Exp Cell Res; 2019 Sep; 382(2):111463. PubMed ID: 31247189
[TBL] [Abstract][Full Text] [Related]
10. Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1/RIPK3/MLKL pathway.
Zhang YY; Liu WN; Li YQ; Zhang XJ; Yang J; Luo XJ; Peng J
Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1085-1095. PubMed ID: 31055628
[TBL] [Abstract][Full Text] [Related]
11. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
Wang Z; Feng J; Yu J; Chen G
J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
[TBL] [Abstract][Full Text] [Related]
12. Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitors.
Kim N; Park CJ; Kim Y; Ryu S; Cho H; Nam Y; Han M; Shin JS; Sim T
Eur J Med Chem; 2023 Nov; 259():115635. PubMed ID: 37494773
[TBL] [Abstract][Full Text] [Related]
13. Novel drug discovery strategies for atherosclerosis that target necrosis and necroptosis.
Coornaert I; Hofmans S; Devisscher L; Augustyns K; Van Der Veken P; De Meyer GRY; Martinet W
Expert Opin Drug Discov; 2018 Jun; 13(6):477-488. PubMed ID: 29598451
[TBL] [Abstract][Full Text] [Related]
14. Caspase-8, receptor-interacting protein kinase 1 (RIPK1), and RIPK3 regulate retinoic acid-induced cell differentiation and necroptosis.
Someda M; Kuroki S; Miyachi H; Tachibana M; Yonehara S
Cell Death Differ; 2020 May; 27(5):1539-1553. PubMed ID: 31659279
[TBL] [Abstract][Full Text] [Related]
15. A cytosolic heat shock protein 90 and co-chaperone p23 complex activates RIPK3/MLKL during necroptosis of endothelial cells in acute respiratory distress syndrome.
Yu X; Mao M; Liu X; Shen T; Li T; Yu H; Zhang J; Chen X; Zhao X; Zhu D
J Mol Med (Berl); 2020 Apr; 98(4):569-583. PubMed ID: 32072232
[TBL] [Abstract][Full Text] [Related]
16. Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis.
Le Cann F; Delehouzé C; Leverrier-Penna S; Filliol A; Comte A; Delalande O; Desban N; Baratte B; Gallais I; Piquet-Pellorce C; Faurez F; Bonnet M; Mettey Y; Goekjian P; Samson M; Vandenabeele P; Bach S; Dimanche-Boitrel MT
FEBS J; 2017 Sep; 284(18):3050-3068. PubMed ID: 28715128
[TBL] [Abstract][Full Text] [Related]
17. Potent Inhibition of Necroptosis by Simultaneously Targeting Multiple Effectors of the Pathway.
Pierotti CL; Tanzer MC; Jacobsen AV; Hildebrand JM; Garnier JM; Sharma P; Lucet IS; Cowan AD; Kersten WJA; Luo MX; Liang LY; Fitzgibbon C; Garnish SE; Hempel A; Nachbur U; Huang DCS; Czabotar PE; Silke J; van Delft MF; Murphy JM; Lessene G
ACS Chem Biol; 2020 Oct; 15(10):2702-2713. PubMed ID: 32902249
[TBL] [Abstract][Full Text] [Related]
18. RIPK1/RIPK3/MLKL-mediated necroptosis contributes to compression-induced rat nucleus pulposus cells death.
Chen S; Lv X; Hu B; Shao Z; Wang B; Ma K; Lin H; Cui M
Apoptosis; 2017 May; 22(5):626-638. PubMed ID: 28289909
[TBL] [Abstract][Full Text] [Related]
19. Targeting RIPK3 oligomerization blocks necroptosis without inducing apoptosis.
Li W; Ni H; Wu S; Han S; Chen C; Li L; Li Y; Gui F; Han J; Deng X
FEBS Lett; 2020 Jul; 594(14):2294-2302. PubMed ID: 32412649
[TBL] [Abstract][Full Text] [Related]
20.
Zhang H; Xu L; Qin X; Chen X; Cong H; Hu L; Chen L; Miao Z; Zhang W; Cai Z; Zhuang C
J Med Chem; 2019 Jul; 62(14):6665-6681. PubMed ID: 31095385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
